Delivery Order SPE2DB22D2009-SPE2DB26FL5YC
- Not listed
- The Defense Logistics Agency awarded a $2,400.91 firm fixed price delivery order to AmerisourceBergen Drug Corp for 90 tablets of Losartan-HCTZ 100-12.5 mg, a common antihypertensive medication combining a angiotensin II receptor blocker with a thiazide diuretic. The order was competitively awarded with no set-aside designation and is scheduled for completion by July 21, 2025. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $24,691.64 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-25 mg tablets (90-count) on August 19, 2025, with completion scheduled for August 20, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's existing Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $2,491.29 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count) on August 11, 2025, with an ultimate completion date of August 12, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and designates Conshohocken, Pennsylvania as the place of performance, which aligns with AmerisourceBergen's corporate headquarters location. The delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $10,121.06 to AmerisourceBergen Drug Corp for Losartan-HCTZ 100-12.5 mg tablets (90-count supply) on September 22, 2025, with completion scheduled for September 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-12.5 mg tablets (90-count) under a firm fixed-price contract valued at $6,392.65. The order was competitively awarded without set-aside designation and is scheduled for completion by September 25, 2025. AmerisourceBergen will perform the contract from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $14,962.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90-tablet supplies of Losartan-HCTZ 100-12.5 mg tablets, with performance in Conshohocken, Pennsylvania and completion by September 15, 2025. This non-set-aside award was competitively procured and represents a routine pharmaceutical supply delivery under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered...
- The Defense Logistics Agency awarded a $1,515.43 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Losartan-HCTZ 50-12.5 mg tablets (90-count). This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. The contract is non-set-aside and was competitively awarded, with an...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $2,400.84 for the supply of Losartan-HCTZ 100-12.5 mg tablets in 90-count packages. This contract, awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award status. The place of performance is listed as Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a $2,162.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Losartan-HCTZ 50-12.5 mg tablets (90-count supply) on August 7, 2025, with a completion date of August 8, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,008.72 to AmerisourceBergen Drug Corp for the supply of Losartan-HCTZ 100-25 mg tablets (90-count) on September 8, 2025, with completion scheduled for September 9, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- SPE2DB22D2009Indefinite Delivery Contract
- SPE2DB22D2009-SPE2DB26FL5YCDelivery Order
The Defense Logistics Agency awarded a $4,646.63 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 90-count tablets of Losartan-HCTZ 50-12.5 mg, a combination antihypertensive medication used to treat high blood pressure. The contract, which was awarded on October 21, 2025, with an ultimate completion date of October 22, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.99 billion ceiling value through December 2026. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's broader federal contract portfolio demonstrates extensive experience delivering a comprehensive range of pharmaceutical products, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This particular delivery order reflects the routine pharmaceutical supply operations under the prime IDC vehicle that enables flexible sourcing of medications and medical commodities to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 10/21/25 |